Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

Background The highest number of COVID-19 cases in Italy have been reported in
Lombardy, a region in northern Italy. We aimed to analyse the course of severe acute …

Background Rheumatoid arthritis has been associated with severe COVID-19, but few
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …

Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with …

Objective To investigate differences in manifestations and outcomes of coronavirus disease
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …

Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Background Over the month of April, Spain has become the European country with more
confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of …

Background Studies on long-term consequences of COVID-19, commonly referred to as post-
COVID condition, in patients with inflammatory rheumatic diseases are scarce and …